acetylcarnitine has been researched along with HIV Coinfection in 16 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-carnitine is a nonessential micronutrient that regulates fatty acid transport into the mitochondrial matrix for metabolism via beta-oxidation." | 2.42 | Acetyl-L-carnitine for the treatment of HIV lipoatrophy. ( Day, L; Gerschenson, M; Shikuma, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milazzo, L | 1 |
| Menzaghi, B | 1 |
| Caramma, I | 1 |
| Nasi, M | 1 |
| Sangaletti, O | 1 |
| Cesari, M | 1 |
| Zanone Poma, B | 1 |
| Cossarizza, A | 2 |
| Antinori, S | 1 |
| Galli, M | 1 |
| Hart, AM | 1 |
| Wilson, AD | 1 |
| Montovani, C | 1 |
| Smith, C | 1 |
| Johnson, M | 1 |
| Terenghi, G | 1 |
| Youle, M | 3 |
| Day, L | 1 |
| Shikuma, C | 1 |
| Gerschenson, M | 1 |
| Osio, M | 2 |
| Muscia, F | 1 |
| Zampini, L | 1 |
| Nascimbene, C | 1 |
| Mailland, E | 1 |
| Cargnel, A | 1 |
| Mariani, C | 1 |
| Famularo, G | 1 |
| Moretti, S | 2 |
| Alesse, E | 2 |
| Trinchieri, V | 1 |
| Angelucci, A | 1 |
| Santini, G | 1 |
| Cifone, G | 1 |
| De Simone, C | 2 |
| Mussini, C | 1 |
| Mongiardo, N | 1 |
| Borghi, V | 1 |
| Sabbatini, A | 1 |
| De Rienzo, B | 1 |
| Franceschi, C | 1 |
| Di Marzio, L | 1 |
| D'Alò, S | 1 |
| Zazzeroni, F | 1 |
| Marcellini, S | 1 |
| Smacchia, C | 1 |
| Cifone, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.[NCT02141035] | Phase 2/Phase 3 | 20 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for acetylcarnitine and HIV Coinfection
| Article | Year |
|---|---|
Acetyl-L-carnitine. Monograph.
Topics: Acetylcarnitine; Alcoholism; Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Cogni | 2010 |
Acetyl-L-carnitine for the treatment of HIV lipoatrophy.
Topics: Acetylcarnitine; Carnitine; Fatty Acids; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Huma | 2004 |
Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.
Topics: Acetylcarnitine; Animals; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; HIV Infec | 2007 |
5 trials available for acetylcarnitine and HIV Coinfection
| Article | Year |
|---|---|
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.
Topics: Absorptiometry, Photon; Acetylcarnitine; Adult; Antioxidants; Body Composition; Breath Tests; Carboh | 2010 |
Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy.
Topics: Acetylcarnitine; Adult; Cohort Studies; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Hu | 2004 |
Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study.
Topics: Acetylcarnitine; Adult; Aged; Antiretroviral Therapy, Highly Active; HIV Infections; Humans; Middle | 2006 |
Complications & side effects. Supplements and CD4+ counts: study finds surprising results.
Topics: Acetylcarnitine; Acetylcysteine; Antioxidants; CD4 Lymphocyte Count; Dose-Response Relationship, Dru | 2004 |
A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
Topics: Acetylcarnitine; Administration, Oral; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infe | 2007 |
8 other studies available for acetylcarnitine and HIV Coinfection
| Article | Year |
|---|---|
Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine.
Topics: Acetylcarnitine; Adult; AIDS Arteritis, Central Nervous System; AIDS Dementia Complex; CD4 Lymphocyt | 1999 |
Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome.
Topics: Acetylcarnitine; Acetylcysteine; Acute Disease; Adult; Antioxidants; Apoptosis; CD4 Lymphocyte Count | 1997 |
Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation.
Topics: Acetylcarnitine; Adult; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Ceramides | 1999 |
Acetyl-L-carnitine.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Depressive Disorder; Diabetic Neuropathies; HIV Infecti | 1999 |
Amino acid may help neuropathy.
Topics: Acetylcarnitine; Anti-HIV Agents; Biopsy; HIV Infections; Humans; Peripheral Nervous System Diseases | 2000 |
What's L-A-C got to do with it?
Topics: Acetylcarnitine; HIV Infections; Humans; Nootropic Agents; Peripheral Nervous System Diseases | 1997 |
Acetylcarnitine and neuropathy: call for information.
Topics: Acetylcarnitine; Clinical Trials as Topic; HIV Infections; Humans; Peripheral Nervous System Disease | 1998 |
. . . from the 3rd International Workshop on salvage therapy for HIV infection.
Topics: Acetylcarnitine; HIV Infections; HIV Protease Inhibitors; Humans; Patient Compliance; Peripheral Ner | 2000 |